Abstract
Positron Emission Tomography (PET) is increasingly being used in radiotherapy planning, with the development of hybrid imaging technology such as PET/CT allowing more accurate volumes being generated for treatment with external beam radiation. This article will discuss the use of FDG PET in radiotherapy planning of various types of malignancies, as well as some pitfalls and practicalities of integrating PET/CT into radiotherapy planning.
Keywords: PET/CT, radiotherapy planning, FDG, IMRT, head & neck carcinoma, lung carcinoma, gastrointestinal carcinoma, gynaecological carcinoma.
Current Radiopharmaceuticals
Title:The Current Role of PET/CT in Radiotherapy Planning
Volume: 8 Issue: 1
Author(s): Sze Ting Lee and Andrew M. Scott
Affiliation:
Keywords: PET/CT, radiotherapy planning, FDG, IMRT, head & neck carcinoma, lung carcinoma, gastrointestinal carcinoma, gynaecological carcinoma.
Abstract: Positron Emission Tomography (PET) is increasingly being used in radiotherapy planning, with the development of hybrid imaging technology such as PET/CT allowing more accurate volumes being generated for treatment with external beam radiation. This article will discuss the use of FDG PET in radiotherapy planning of various types of malignancies, as well as some pitfalls and practicalities of integrating PET/CT into radiotherapy planning.
Export Options
About this article
Cite this article as:
Lee Ting Sze and Scott M. Andrew, The Current Role of PET/CT in Radiotherapy Planning, Current Radiopharmaceuticals 2015; 8 (1) . https://dx.doi.org/10.2174/1874471008666150316222618
DOI https://dx.doi.org/10.2174/1874471008666150316222618 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
α7 nAChR in Airway Respiratory Epithelial Cells
Current Drug Targets Radiobromine-Labelled Tracers for Positron Emission Tomography: Possibilities and Pitfalls
Current Radiopharmaceuticals Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor
Current Respiratory Medicine Reviews PET Designated Flouride-18 Production and Chemistry
Current Topics in Medicinal Chemistry Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Current Pharmaceutical Design Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Subject Index to Volume 4
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Genetic Landscapes of Inflammation-Driven Gastrointestinal Tract Cancers
Current Pharmaceutical Design Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Recent Patents on Anti-Cancer Drug Discovery Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis
Current Radiopharmaceuticals Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Lung Cancer and Radiological Imaging
Current Radiopharmaceuticals PET with Non-Standard Nuclides
Current Topics in Medicinal Chemistry Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
Current Pharmaceutical Design Radiation Therapy in the Early 21st Century: Technological Advances
Current Cancer Therapy Reviews Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry